US2016128955A1PendingUtilityA1
Injectable supersaturated acetaminophen solution for spinal administration
Est. expiryJun 29, 2032(~5.9 yrs left)· nominal 20-yr term from priority
A61P 29/02A61P 29/00A61P 23/02A61K 31/445A61K 31/245A61K 31/165A61K 9/0085A61K 31/167A61K 31/47A61K 31/381A61K 9/0019A61K 9/08
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to an acetaminophen injectable aqueous solution for use in the treatment or in the prevention of pain by spinal administration, wherein said acetaminophen injectable solution is supersaturated. In certain embodiments, the acetaminophen injectable aqueous solution is administered simultaneously, separately or sequentially with a local anaesthetic by spinal administration.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A method of providing analgesia comprising:
spinally administering a stable acetaminophen supersaturated injectable aqueous solution, wherein said supersaturated injectable aqueous solution comprises a solvent which is degassed or substantially oxygen or air free and comprises acetaminophen in a concentration greater than 1.8 w/v.
13 . The method according to claim 12 , wherein the acetaminophen concentration is ranging from 1.8 to 8.0% w/v.
14 . The method according to claim 12 wherein said injectable aqueous solution is substantially free of preservatives, and/or additives and/or co-solvents.
15 . The method according to claim 12 , obtained by degassing water by a flow of an inert gas and by dissolving acetaminophen therein in an amount to give a supersaturated solution.
16 . The method according to claim 12 in the treatment of post-surgical pain.
17 . The method according to claim 12 further comprising the simultaneous, separate or sequential spinal administration with a local anaesthetic.
18 . The method according to claim 17 wherein the acetaminophen solution is added to or mixed with a solution of a local anaesthetic for spinal administration.
19 . The method according to claim 17 wherein said local anaesthetic is a short-acting local anaesthetic selected from lidocaine, articaine, oxybuprocaine, chloroprocaine or a medium-acting local anaesthetic selected from prilocaine, mepivacaine, etidocaine or a long-acting local anaesthetic selected from ropivacaine, bupivacaine, cinchocaine, levobupivacaine, proxymetacaine, tetracaine.
20 . The method according to claim 17 for the combined analgesic-anaesthetic treatment.
21 . The method according to claim 17 wherein the analgesic effect of acetaminophen has a longer duration than the analgesic effect of the local anaesthetic.
22 . The method according to claim 17 wherein the local anaesthetic and acetaminophen exert an analgesic effect even after the end of the anaesthetic effect caused by the local anaesthetic.Join the waitlist — get patent alerts
Track US2016128955A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.